NEW YORK (GenomeWeb News) – Vanderbilt University is partnering with GE Global Research to evaluate GE's cancer mapping technology for cellular insight into colon tumors.

The partnership, announced today and supported by a five-year, $3.75 million grant from the Office of the Director of the National Institutes of Health, will test GE's automated platform that can probe and analyze up to 60 different disease biomarkers, including proteins and messenger RNAs, in a single tissue sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.